{"id":"https://openalex.org/W7225004664","doi":"https://doi.org/10.4084/mjhid.2026.087","title":"MOLECULAR MARKERS IN AML: PROGNOSTC IMPLICATIONS AND IMPACT ON TREATMENT DECISION-MAKING","display_name":"MOLECULAR MARKERS IN AML: PROGNOSTC IMPLICATIONS AND IMPACT ON TREATMENT DECISION-MAKING","publication_year":2026,"publication_date":"2026-10-31","ids":{"openalex":"https://openalex.org/W7225004664","doi":"https://doi.org/10.4084/mjhid.2026.087"},"language":"en","primary_location":{"id":"doi:10.4084/mjhid.2026.087","doi":"https://doi.org/10.4084/mjhid.2026.087","is_oa":true,"landing_page_url":"https://doi.org/10.4084/mjhid.2026.087","pdf_url":"https://www.mjhid.org/mjhid/article/download/6538/4997","source":{"id":"https://openalex.org/S159911762","display_name":"Mediterranean Journal of Hematology and Infectious Diseases","issn_l":"2035-3006","issn":["2035-3006"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319913","host_organization_name":"PAGEPress (Italy)","host_organization_lineage":["https://openalex.org/P4310319913"],"host_organization_lineage_names":["PAGEPress (Italy)"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mediterranean Journal of Hematology and Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mjhid.org/mjhid/article/download/6538/4997","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5158685956","display_name":"Patrizia Chiusolo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I103320735","display_name":"Universit\u00e0 Cattolica del Sacro Cuore","ror":"https://ror.org/03h7r5v07","country_code":"IT","type":"education","lineage":["https://openalex.org/I103320735"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Patrizia Chiusolo","raw_affiliation_strings":["Hematology Department, Universit\u00e0 Cattolica S. Cuore, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Universit\u00e0 Cattolica S. Cuore, Rome, Italy","institution_ids":["https://openalex.org/I103320735"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009283840","display_name":"Roberto Maggi","orcid":"https://orcid.org/0000-0002-2733-513X","observed_orcids":["https://orcid.org/0000-0002-2733-513X"]},"institutions":[{"id":"https://openalex.org/I103320735","display_name":"Universit\u00e0 Cattolica del Sacro Cuore","ror":"https://ror.org/03h7r5v07","country_code":"IT","type":"education","lineage":["https://openalex.org/I103320735"]},{"id":"https://openalex.org/I2802557943","display_name":"Agostino Gemelli University Polyclinic","ror":"https://ror.org/00rg70c39","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I2802557943"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Roberto Maggi","raw_affiliation_strings":["Universita Cattolica del Sacro Cuore/Policlinico Gemelli"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universita Cattolica del Sacro Cuore/Policlinico Gemelli","institution_ids":["https://openalex.org/I103320735","https://openalex.org/I2802557943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040830021","display_name":"Angela Alessi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802557943","display_name":"Agostino Gemelli University Polyclinic","ror":"https://ror.org/00rg70c39","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I2802557943"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Angela Alessi","raw_affiliation_strings":["Policlinico Gemelli. Roma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Policlinico Gemelli. Roma","institution_ids":["https://openalex.org/I2802557943"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105408894","display_name":"Simona Sica","orcid":"https://orcid.org/0000-0003-4459-9687","observed_orcids":["https://orcid.org/0000-0003-4459-9687"]},"institutions":[{"id":"https://openalex.org/I103320735","display_name":"Universit\u00e0 Cattolica del Sacro Cuore","ror":"https://ror.org/03h7r5v07","country_code":"IT","type":"education","lineage":["https://openalex.org/I103320735"]},{"id":"https://openalex.org/I2802557943","display_name":"Agostino Gemelli University Polyclinic","ror":"https://ror.org/00rg70c39","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I2802557943"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Simona Sica","raw_affiliation_strings":["Universit\u00e0 Cattolica del Sacro Cuore/policlinico Gemelli"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e0 Cattolica del Sacro Cuore/policlinico Gemelli","institution_ids":["https://openalex.org/I103320735","https://openalex.org/I2802557943"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":600,"currency":"EUR","value_usd":647},"apc_paid":{"value":600,"currency":"EUR","value_usd":647},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.86418046,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"1","first_page":"e2026087","last_page":"e2026087"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":1.0},{"id":"https://openalex.org/keywords/molecular-markers","display_name":"molecular markers","score":0.8529999852180481},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8980000019073486},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.8610000014305115},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.8259999752044678},{"id":"https://openalex.org/keywords/flt3-mutation","display_name":"FLT3 mutation","score":0.8700000047683716},{"id":"https://openalex.org/keywords/idh1-2-mutation","display_name":"IDH1/2 mutation","score":0.9200000166893005},{"id":"https://openalex.org/keywords/npm1-mutation","display_name":"NPM1 mutation","score":0.9950000047683716},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":1.0},{"id":"https://openalex.org/keywords/kit-mutations","display_name":"KIT mutations","score":0.8320000171661377},{"id":"https://openalex.org/keywords/core-binding-factor-aml","display_name":"core binding factor AML","score":0.9570000171661377},{"id":"https://openalex.org/keywords/menin-inhibitors","display_name":"menin inhibitors","score":0.8420000076293945},{"id":"https://openalex.org/keywords/co-mutations","display_name":"co-occurring mutations","score":0.6309999823570251},{"id":"https://openalex.org/keywords/clonal-hierarchy","display_name":"clonal hierarchy","score":0.8790000081062317},{"id":"https://openalex.org/keywords/variant-allele-frequency","display_name":"variant allele frequency","score":0.9110000133514404},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.7940000295639038},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.9760000109672546},{"id":"https://openalex.org/keywords/relapse-management","display_name":"relapse management","score":0.6579999923706055},{"id":"https://openalex.org/keywords/next-generation-sequencing","display_name":"next-generation sequencing","score":0.5709999799728394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8364999890327454},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6154000163078308},{"id":"https://openalex.org/C179786068","wikidata":"https://www.wikidata.org/wiki/Q16257937","display_name":"Molecular diagnostics","level":2,"score":0.5546000003814697},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.5267999768257141},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5160999894142151},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.4778999984264374},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4700999855995178},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.44279998540878296},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.4325000047683716},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.40630000829696655},{"id":"https://openalex.org/C189206191","wikidata":"https://www.wikidata.org/wiki/Q222046","display_name":"Genomics","level":4,"score":0.37630000710487366},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.3619999885559082},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35989999771118164},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.3427000045776367},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.3409999907016754},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.33799999952316284},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.33660000562667847},{"id":"https://openalex.org/C174475383","wikidata":"https://www.wikidata.org/wiki/Q246128","display_name":"Cytogenetics","level":4,"score":0.33239999413490295},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.3285999894142151},{"id":"https://openalex.org/C170734499","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenomics","level":2,"score":0.31029999256134033},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.3068000078201294},{"id":"https://openalex.org/C204315192","wikidata":"https://www.wikidata.org/wiki/Q210506","display_name":"Molecular genetics","level":3,"score":0.30570000410079956},{"id":"https://openalex.org/C68838962","wikidata":"https://www.wikidata.org/wiki/Q852654","display_name":"Haploinsufficiency","level":4,"score":0.30399999022483826},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.30329999327659607},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.29750001430511475},{"id":"https://openalex.org/C3019646584","wikidata":"https://www.wikidata.org/wiki/Q2311855","display_name":"Molecular biomarkers","level":2,"score":0.2921999990940094},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.28450000286102295},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.2754000127315521},{"id":"https://openalex.org/C2780673598","wikidata":"https://www.wikidata.org/wiki/Q285223","display_name":"Genetic testing","level":2,"score":0.2720000147819519},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.2678999900817871},{"id":"https://openalex.org/C2777160741","wikidata":"https://www.wikidata.org/wiki/Q2311855","display_name":"Molecular marker","level":3,"score":0.25870001316070557},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.25690001249313354},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.25609999895095825}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.4084/mjhid.2026.087","doi":"https://doi.org/10.4084/mjhid.2026.087","is_oa":true,"landing_page_url":"https://doi.org/10.4084/mjhid.2026.087","pdf_url":"https://www.mjhid.org/mjhid/article/download/6538/4997","source":{"id":"https://openalex.org/S159911762","display_name":"Mediterranean Journal of Hematology and Infectious Diseases","issn_l":"2035-3006","issn":["2035-3006"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319913","host_organization_name":"PAGEPress (Italy)","host_organization_lineage":["https://openalex.org/P4310319913"],"host_organization_lineage_names":["PAGEPress (Italy)"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mediterranean Journal of Hematology and Infectious Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.4084/mjhid.2026.087","doi":"https://doi.org/10.4084/mjhid.2026.087","is_oa":true,"landing_page_url":"https://doi.org/10.4084/mjhid.2026.087","pdf_url":"https://www.mjhid.org/mjhid/article/download/6538/4997","source":{"id":"https://openalex.org/S159911762","display_name":"Mediterranean Journal of Hematology and Infectious Diseases","issn_l":"2035-3006","issn":["2035-3006"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319913","host_organization_name":"PAGEPress (Italy)","host_organization_lineage":["https://openalex.org/P4310319913"],"host_organization_lineage_names":["PAGEPress (Italy)"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mediterranean Journal of Hematology and Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225004664.pdf","grobid_xml":"https://content.openalex.org/works/W7225004664.grobid-xml"},"referenced_works_count":58,"referenced_works":["https://openalex.org/W1255676896","https://openalex.org/W1995675594","https://openalex.org/W2028988847","https://openalex.org/W2063092678","https://openalex.org/W2078972833","https://openalex.org/W2107027906","https://openalex.org/W2109726093","https://openalex.org/W2110828128","https://openalex.org/W2115707319","https://openalex.org/W2127738065","https://openalex.org/W2131072337","https://openalex.org/W2131860315","https://openalex.org/W2137881702","https://openalex.org/W2146862320","https://openalex.org/W2152496375","https://openalex.org/W2153010521","https://openalex.org/W2170515966","https://openalex.org/W2276580523","https://openalex.org/W2419140434","https://openalex.org/W2623089849","https://openalex.org/W2715749014","https://openalex.org/W2806682325","https://openalex.org/W2899472109","https://openalex.org/W2922692686","https://openalex.org/W2939577741","https://openalex.org/W2982353618","https://openalex.org/W2993435749","https://openalex.org/W3000515035","https://openalex.org/W3013447738","https://openalex.org/W3042846071","https://openalex.org/W3048827006","https://openalex.org/W3094256944","https://openalex.org/W3112827655","https://openalex.org/W3130105428","https://openalex.org/W3209416216","https://openalex.org/W4224290890","https://openalex.org/W4284884567","https://openalex.org/W4295903227","https://openalex.org/W4366977509","https://openalex.org/W4389975150","https://openalex.org/W4392691406","https://openalex.org/W4401441260","https://openalex.org/W4401504076","https://openalex.org/W4401504326","https://openalex.org/W4405048305","https://openalex.org/W4407953944","https://openalex.org/W4410158978","https://openalex.org/W4411236987","https://openalex.org/W4413377686","https://openalex.org/W4414498177","https://openalex.org/W4417001899","https://openalex.org/W4417010339","https://openalex.org/W7123747975","https://openalex.org/W7153108946","https://openalex.org/W7163527832","https://openalex.org/W7164352178","https://openalex.org/W7166105016","https://openalex.org/W7167080163"],"related_works":["https://openalex.org/W4318754393","https://openalex.org/W2057400290","https://openalex.org/W2942283750","https://openalex.org/W2008872234","https://openalex.org/W2890677405","https://openalex.org/W4304891786","https://openalex.org/W3013201614","https://openalex.org/W4200291521","https://openalex.org/W2567727571","https://openalex.org/W2182315038"],"abstract_inverted_index":{"Acute":[0],"myeloid":[1],"leukemia":[2],"(AML)":[3],"is":[4,88,216],"a":[5],"biologically":[6],"heterogeneous":[7],"hematologic":[8],"malignancy":[9],"in":[10,76,116,178],"which":[11],"recurrent":[12],"cytogenetic":[13],"and":[14,29,50,52,107,119,134,161,171,194,209,243],"molecular":[15,43,86,153,176,218],"abnormalities":[16,219],"critically":[17],"influence":[18],"diagnostic":[19],"classification,":[20],"prognosis,":[21],"therapeutic":[22,56,96,211],"allocation,":[23],"measurable":[24],"residual":[25],"disease":[26,163],"(MRD)":[27],"assessment,":[28],"relapse":[30,244],"biology.":[31],"Over":[32],"the":[33,42,77,168],"last":[34],"decade,":[35],"next-generation":[36],"sequencing":[37],"(NGS)":[38],"has":[39],"profoundly":[40,112],"expanded":[41],"characterization":[44],"of":[45,79,174,233],"AML,":[46,179,183,185,187,193],"complementing":[47],"morphology,":[48],"immunophenotyping,":[49],"cytogenetics":[51],"enabling":[53],"increasingly":[54,89,149],"personalized":[55],"strategies.":[57],"The":[58,213],"European":[59],"LeukemiaNet":[60],"(ELN)":[61],"2022":[62],"recommendations":[63],"established":[64],"an":[65],"integrated":[66],"cytogenetic-molecular":[67],"backbone":[68],"for":[69],"risk":[70,87,200],"stratification.":[71],"In":[72,98],"contrast,":[73],"subsequent":[74],"refinements":[75],"era":[78],"hypomethylating":[80],"agents":[81],"plus":[82],"venetoclax":[83],"demonstrated":[84],"that":[85,126,217],"treatment-dependent":[90,199],"rather":[91,229],"than":[92],"universally":[93],"fixed":[94],"across":[95],"platforms.":[97],"parallel,":[99],"targeted":[100],"therapies":[101],"against":[102],"FLT3,":[103],"IDH1/2,":[104],"BCL2,":[105],"CD33,":[106],"menin-dependent":[108],"transcriptional":[109],"programs":[110],"have":[111],"reshaped":[113],"AML":[114,147],"management":[115,148,245],"both":[117],"fit":[118],"unfit":[120],"patients.":[121],"Emerging":[122],"data":[123],"further":[124],"indicate":[125],"co-mutational":[127,202],"architecture,":[128],"clonal":[129],"hierarchy,":[130],"variant":[131],"allele":[132],"frequency,":[133],"MRD":[135],"kinetics":[136],"may":[137],"refine":[138],"prognostic":[139,170,226],"assessment":[140],"beyond":[141],"traditional":[142],"single-gene":[143],"models.":[144],"Consequently,":[145],"modern":[146],"relies":[150],"on":[151,181],"dynamic":[152],"interpretation":[154],"integrating":[155],"baseline":[156],"genomics":[157],"with":[158,198],"treatment":[159],"response":[160],"longitudinal":[162],"monitoring.":[164],"This":[165],"review":[166],"discusses":[167],"current":[169],"predictive":[172],"role":[173],"major":[175],"markers":[177],"focusing":[180],"FLT3-mutated":[182],"IDH1/2-mutated":[184],"NPM1-mutated":[186],"TP53-mutated":[188],"disease,":[189],"KIT-mutated":[190],"core-binding":[191],"factor":[192],"KMT2A/NUP98-driven":[195],"leukemias,":[196],"together":[197],"stratification,":[201],"refinement,":[203],"menin":[204],"inhibitors,":[205],"germline":[206],"predisposition":[207],"syndromes,":[208],"MRD-guided":[210],"adaptation.":[212],"central":[214],"concept":[215],"should":[220],"no":[221],"longer":[222],"be":[223],"considered":[224],"static":[225],"labels,":[227],"but":[228],"operational":[230],"biomarkers":[231],"capable":[232],"guiding":[234],"time-sensitive":[235],"clinical":[236],"decisions":[237],"from":[238],"diagnosis":[239],"through":[240],"post-transplant":[241],"surveillance":[242]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-11-01T00:00:00"}